Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01417195 · ClinicalTrials.gov registry record · Phase 4
Menopur Mixed Protocol
A Phase 4 study of Infertility, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 122
- Enrollment target
- 10
- Study locations
NCT01417195 is a Phase 4 study of Infertility that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 122 participants, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 10 study locations across 7 states.
The verdict
NCT01417195, a Phase 4 study of Infertility, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 122 participants
- Enrollment target
- 10
- Study locations
Study Summary
The objective of this study was to compare the fertilization rate between the combination of Menopur and Bravelle mixed in the same syringe and Menopur alone, both administered subcutaneously (SC), in subjects undergoing Assisted Reproductive Technology (ART). Additionally the study assessed subjects' ability to mix and store the combination of Menopur and Bravelle and to assess safety of the Menopur and Bravelle combination.
Conditions Studied
Interventions
- DRUG Bravelle
- DRUG Menopur
Study Locations (10)
Texas
- The Center for Assisted Reproduction - Bedford
- Houston Fertility Institute - Houston
- Center of Reproductive Medicine - Webster
Illinois
- Fertility Center of Illinois - Chicago
- The Advanced IVF Institute - Naperville
Colorado
- Colorado Center for Reproductive Medicine - Lone Tree
Florida
- Women's Medical Research Group - Clearwater
Georgia
- Reproductive Biology Associates - Atlanta
Maryland
- Shady Grove Fertility - Rockville
Washington
- Seattle Reproductive Medicine - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01417195
The ClinicalTrials.gov registry entry for NCT01417195 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Bravelle is the first listed.
NCT01417195 reports 10 study locations spanning 7 distinct geographic areas - top geographies include Texas, Illinois, Colorado.
Frequently Asked Questions
What is clinical trial NCT01417195 about?
NCT01417195 is a clinical study titled "Menopur Mixed Protocol". The objective of this study was to compare the fertilization rate between the combination of Menopur and Bravelle mixed in the same syringe and Menopur alone, both administered subcutaneously (SC), in subjects undergoing Assisted Reproductive Technology (ART). Additionally the study assessed subject...
What is the current status of trial NCT01417195?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 122 participants. The study started on 2011-07. Estimated completion is 2012-01.
What conditions does trial NCT01417195 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT01417195?
The interventions under investigation include: Bravelle (DRUG), Menopur (DRUG).
Who is sponsoring clinical trial NCT01417195?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01417195 being conducted?
This trial has 10 study locations across Colorado, Florida, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GnRH for Luteal Support in IVF/ICSI/FET Cycles
RECRUITING · Phase 4
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
COMPLETED · Phase 4
-
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial
COMPLETED · Phase 4
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.